Article Details

Zacks: Analysts Expect Intellia Therapeutics, Inc. (NASDAQ:NTLA) Will Post Quarterly Sales ...

Retrieved on: 2021-10-11 08:25:04

Tags for this article:

Click the tags to see associated articles and topics

Zacks: Analysts Expect Intellia Therapeutics, Inc. (NASDAQ:NTLA) Will Post Quarterly Sales .... View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nasdaq-ntla-consensus-analyst-rating-2021-10-2-3/

Excerpt

Vanguard Group Inc. now owns 6,026,177 shares of the company's stock valued at $975,698,000 after acquiring an additional 447,433 shares during the last quarter ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up